# US 10,863,934 B2 · Blood lipid concentration measurement device and method for operating same > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 10,863,934 B2 - Document ID: US10863934B2 - Status: Granted - Kind: B2 - Application number: 16/301,108 - Filed: 2017-02-14 - Published: 2019-06-27 - Granted: 2020-12-15 - Earliest claimed: 2016-05-18 - Assignees: Medical Photonics Co., Ltd. - Applicants: Medical Photonics Co., Ltd. - Inventors: Kazuya Iinaga - Web page: https://patentgrep.com/patent/US10863934B2 ## CPC - A61B 5/1455: using optical sensors, e.g. spectral photometrical oximeters - A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes} - A61B 5/4866: {Evaluating metabolism (using breath test A61B5/083)} - A61B 5/7271: {Specific aspects of physiological measurement analysis (specific diagnostics methods using bioelectric or biomagnetic signals A61B5/316)} - G01N 21/17: Systems in which incident light is modified in accordance with the properties of the material investigated (where the material investigated is optically excited causing a change in wavelength of the incident light G01N21/63) - A61B 5/1495: Calibrating or testing of in-vivo probes - A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor} - A61B 2562/0238: Optical sensor arrangements for performing transmission measurements on body tissue - A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D) - G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q) ## Abstract A device and method for measuring levels of individual lipids in a lipoprotein, the device being equipped with: an irradiation unit that can emit irradiation light having a first wavelength and irradiation light having a second wavelength at predetermined light intensities toward the inside of a living body from outside of the living body; a light intensity detection unit arranged at a predetermined distance apart from a position at which light is emitted from the irradiation unit or is arranged adjacent to the position, and can detect the intensities of first light and second light both emitted from the living body; a scattering coefficient calculation unit that can calculate a first scattering coefficient and a second scattering coefficient in the living body respectively on the basis of the intensities of a first light and a second light detected by the light intensity detection unit; and a lipid level calculation unit. ## Claims ### Claim 1 A blood particle concentration measurement device comprising: an irradiation portion configured to irradiate irradiation light having a first wavelength and irradiation light having a second wavelength shorter than the first wavelength at predetermined light intensities toward an inside of a living body from an outside of the living body; a light intensity detection portion configured to detect an intensity of first light and an intensity of second light both emitted from the living body to measure a radiation-detection distance dependent attenuation of light intensities of the radiated irradiation light having the first wavelength and the radiated irradiation light having the second wavelength, the light intensity detection portion being disposed at a predetermined interval from or continuously to a light irradiation position of the irradiation portion; a scattering coefficient calculation portion configured to calculate a first scattering coefficient and a second scattering coefficient in the living body respectively on a basis of the first light intensity and the second light intensity detected by the light intensity detection portion; and a particle concentration calculation portion configured to calculate a variation of a concentration of a second particle group in the blood on a basis of a variation of the second scattering coefficient and calculate a variation of a concentration of a first particle group including a particle whose particle diameter is equal to or less than that of a particle included in the second particle group on a basis of a variation of the first scattering coefficient. ### Claim 2 (depends on 1) The blood particle concentration measurement device according to claim 1, wherein the particle concentration calculation portion calculates a variation of a concentration of a particle that is not duplicated between the first particle group and the second particle group from a difference between the variation of the concentration of the first particle group and the variation of the concentration of the second particle group. ### Claim 3 (depends on 1) The blood particle concentration measurement device according to claim 1, further comprising a physical condition determination portion configured to determine a physical condition on a basis of the variation of the concentration of the first particle group and the variation of the concentration of the second particle group. ### Claim 4 (depends on 3) The blood particle concentration measurement device according to claim 3, wherein the physical condition determination portion determines a course of action to improve a lipid balance from a difference between the variation of the concentration of the first particle group and the variation of the concentration of the second particle group. ### Claim 5 (depends on 1) The blood particle concentration measurement device according to claim 1, wherein the first wavelength is 750 nm or more and the second wavelength is shorter than the first wavelength and 900 nm or less. ### Claim 6 (depends on 1) The blood particle concentration measurement device according to claim 1, wherein the first particle group includes at least one of CM and a CM remnant and at least one of VLDL and a VLDL remnant, and the second particle group includes at least one of CM and a CM remnant. ### Claim 7 (depends on 6) The blood particle concentration measurement device according to claim 6, wherein the physical condition determination portion determines a total absorption amount of alcohol or fats from a temporal change in a concentration of the at least one of VLDL and a VLDL remnant. ### Claim 8 (depends on 6) The blood particle concentration measurement device according to claim 6, wherein the physical condition determination portion determines a risk of arteriosclerosis from a temporal change in a concentration of the at least one of CM and a CM remnant. ### Claim 9 (depends on 1) The blood particle concentration measurement device according to claim 1, wherein the irradiation position and a detection position at which the light intensity is detected are arranged apart from each other by a predetermined radiation-detection distance, and the light intensity detection portion detects a light intensity of back scattered light scattered by a particle in the blood. ### Claim 10 (depends on 1) The blood particle concentration measurement device according to claim 1, wherein the irradiation portion is a light source that emits continuous light, the light source radiates light, and a plurality of the light intensity detection portions disposed at different distances from the irradiation position serving as a substantial center detect light intensities at respective detection positions, and the scattering coefficient calculation portion calculates a light scattering coefficient in the living body on a basis of a ratio or difference between the respective light intensities detected by the respective light intensity detection portions. ### Claim 11 A blood lipid concentration measurement device comprising: an irradiation portion configured to radiate irradiation light having a wavelength of 900 nm or less at a predetermined light intensity toward an inside of a living body from an outside of the living body; a light intensity detection portion configured to detect an intensity of light emitted from the living body to measure a radiation-detection distance dependent attenuation of a light intensity of the radiated irradiation light, the light intensity detection portion being disposed at a predetermined interval from or continuously to a light irradiation position of the irradiation portion; a scattering coefficient calculation portion configured to calculate a scattering coefficient in the living body on a basis of the light intensity detected by the light intensity detection portion; and a lipid concentration calculation portion configured to calculate a variation of only a concentration of at least one of CM and a CM remnant in the blood on a basis of a variation of the scattering coefficient. ### Claim 12 (depends on 11) The blood lipid concentration measurement device according to claim 11, further comprising a physical condition determination portion configured to determine a physical condition on a basis of the variation of the concentration of the at least one of CM and a CM remnant. ### Claim 13 (depends on 12) The blood lipid concentration measurement device according to claim 12, wherein the physical condition determination portion determines a risk of arteriosclerosis from a temporal change in the concentration of at least one of CM and a CM remnant. ### Claim 14 A method for operating a blood particle concentration measurement device comprising: an irradiation step of radiating irradiation light having a first wavelength and irradiation light having a second wavelength shorter than the first wavelength at predetermined light intensities toward an inside of a living body from an outside of the living body; a light intensity detection step of detecting an intensity of first light and an intensity of second light both emitted from the living body to measure a radiation-detection distance dependent attenuation of light intensities of the radiated irradiation light having the first wavelength and the radiated irradiation light having the second wavelength at a position with a predetermined interval from or continuously to a light irradiation position in the irradiation step; a scattering coefficient calculation step of calculating a first scattering coefficient and a second scattering coefficient in the living body respectively on a basis of the first light intensity and the second light intensity detected in the light intensity detection step; and a particle concentration calculation step of calculating a variation of a concentration of a second particle group in the blood on a basis of a variation of the second scattering coefficient and calculating a variation of a concentration of a first particle group including a particle whose particle diameter is equal to or less than that of a particle included in the second particle group on a basis of a variation of the first scattering coefficient. ### Claim 15 (depends on 14) The method for operating a blood particle concentration measurement device according to claim 14, wherein in the particle concentration calculation step, a variation of a concentration of a particle that is not duplicated between the first particle group and the second particle group is calculated from a difference between the variation of the concentration of the first particle group and the variation of the concentration of the second particle group. ### Claim 16 (depends on 14) The method for operating a blood particle concentration measurement device according to claim 14, wherein the first wavelength is 750 nm or more and the second wavelength is shorter than the first wavelength and 900 nm or less. ### Claim 17 (depends on 14) The method for operating a blood particle concentration measurement device according to claim 14, wherein the first particle group includes at least one of CM and a CM remnant and at least one of VLDL and a VLDL remnant, and the second particle group includes at least one of CM and a CM remnant. ### Claim 18 A method for operating a blood lipid concentration measurement device comprising: an irradiation step of radiating irradiation light having a wavelength of 900 nm or less at a predetermined light intensity toward an inside of a living body from an outside of the living body; a light intensity detection step of detecting an intensity of light emitted from the living body to measure a radiation-detection distance dependent attenuation of a light intensity of the radiated irradiation light at a position with a predetermined interval from or continuously to a light irradiation position in the irradiation step; a scattering coefficient calculation step of calculating a scattering coefficient in the living body on a basis of the light intensity detected in the light intensity detection step; and a lipid concentration calculation step of calculating a variation of a concentration of at least one of CM and a CM remnant in the blood on a basis of a variation of the scattering coefficient. ### Claim 19 A blood particle concentration measurement device configured to be communicatively connected to a user device, the user device including: an irradiation portion configured to radiate irradiation light having a first wavelength and irradiation light having a second wavelength shorter than the first wavelength at predetermined light intensities toward an inside of a living body from an outside of the living body; a light intensity detection portion configured to detect an intensity of first light and an intensity of second light both emitted from the living body to measure a radiation-detection distance dependent attenuation of light intensities of the radiated irradiation light having the first wavelength and the radiated irradiation light having the second wavelength, the light intensity detection portion being disposed at a predetermined interval from or continuously to a light irradiation position of the irradiation portion; and a communication portion configured to send the first light intensity and the second light intensity detected by the light intensity detection portion, the blood particle concentration measurement device comprising: a scattering coefficient calculation portion configured to calculate a first scattering coefficient and a second scattering coefficient in the living body respectively on a basis of the first light intensity and the second light intensity sent from the user device; and a particle concentration calculation portion configured to calculate a variation of a concentration of a second particle group in the blood on a basis of a variation of the second scattering coefficient and calculate a variation of a concentration of a first particle group including a particle whose particle diameter is equal to or less than that of a particle included in the second particle group on a basis of a variation of the first scattering coefficient. ### Claim 20 A blood lipid concentration measurement device configured to be communicatively connected to a user device, the user device including: an irradiation portion configured to radiate irradiation light having a wavelength of 900 nm or less at a predetermined light intensity toward an inside of a living body from an outside of the living body; a light intensity detection portion configured to detect an intensity of light emitted from the living body to measure a radiation-detection distance dependent attenuation of a light intensity of the radiated irradiation light, the light intensity detection portion being disposed at a predetermined interval from or continuously to a light irradiation position of the irradiation portion; and a communication portion configured to send the light intensity detected by the light intensity detection portion, the blood lipid concentration measurement device comprising: a scattering coefficient calculation portion configured to calculate a scattering coefficient in the living body on a basis of the light intensity sent from the user device; and a lipid concentration calculation portion configured to calculate a variation of only a concentration of at least one of CM and a CM remnant in the blood on a basis of a variation of the scattering coefficient.